Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-026739
Filing Date
2024-11-13
Accepted
2024-11-13 17:34:42
Documents
1
Period of Report
2024-11-11

Document Format Files

Seq Description Document Type Size
1 form4-11132024_101138.html 4  
1 form4-11132024_101138.xml 4 4082
  Complete submission text file 0001415889-24-026739.txt   5529
Mailing Address 675 WEST KENDALL STREET HENRI A. TERMEER SQUARE CAMBRIDGE MA 02142
Business Address
Tanguler Tolga (Reporting) CIK: 0001849458 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41855 | Film No.: 241455861

Mailing Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010 (212) 547-9879
Lexeo Therapeutics, Inc. (Issuer) CIK: 0001907108 (see all company filings)

EIN.: 854012572 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)